(Q50562471)

15 March 2018

meta-analysis

0 references

title

The effects of cannabis on memory function in users with and without a psychotic disorder: findings from a combined meta-analysis. (English)

1 reference

15 March 2018

1 reference

1 reference

4

1 reference

15 March 2018

Sagnik Bhattacharyya

5

1 reference

15 March 2018

author name string

T Schoeler

1

1 reference

15 March 2018

J Kambeitz

2

1 reference

15 March 2018

I Behlke

3

1 reference

15 March 2018

language of work or name

English

0 references

publication date

10 September 2015

1 reference

15 March 2018

published in

Psychological Medicine

1 reference

15 March 2018

volume

46

1 reference

15 March 2018

issue

1

1 reference

15 March 2018

page(s)

177-188

1 reference

15 March 2018

Neuropsychological performance in long-term cannabis users

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Early-onset cannabis use and cognitive deficits: what is the nature of the association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Learning and memory functions of the Basal Ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Reversible effects of acute and long-term administration of delta-9-tetrahydrocannabinol (THC) on memory in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Cannabinoid receptor localization in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Age of onset of marijuana use and executive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Nonacute (residual) neuropsychological effects of cannabis use: a qualitative analysis and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Neurocognitive consequences of marihuana--a comparison with pre-drug performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Regional brain abnormalities associated with long-term heavy cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Interactions between specific parameters of cannabis use and verbal memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Cannabis use, cognitive performance and mood in a sample of workers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

The differential effect of illicit drug use on cognitive function in first-episode psychosis and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Effect of illegal substance use on cognitive function in individuals with a psychotic disorder: a review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Cannabis use and cognitive function: 8-year trajectory in a young adult cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Is schizophrenia a neurodevelopmental disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Persistent cannabis users show neuropsychological decline from childhood to midlife

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

A meta-analysis of depression severity and cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Altered brain tissue composition in heavy marijuana users

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Predictors of cognition in first episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Patient attributes and expressed emotion as risk factors for psychotic relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Marijuana effects on human forgetting functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Effect of BDNF val(66)met polymorphism on declarative memory and its neural substrate: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Long-term effects of frequent cannabis use on working memory and attention: an fMRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

21 January 2018

Cannabis and the brain

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Age differences in Wechsler Memory Scale scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Cannabis use and cognitive functions in at-risk mental state and first episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Cannabis use, cognition and brain structure in first-episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Differential association between chronic cannabis use and brain function deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Methods for exploring heterogeneity in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

The chronic effects of cannabis on memory in humans: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

The role of cannabis in cognitive functioning of patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Neurological soft signs in patients with psychosis and cannabis abuse: a systematic review and meta-analysis of paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

The acute effects of cannabinoids on memory in humans: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Cannabis users have higher premorbid IQ than other patients with first onset psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

Characteristics of substance-abusing persons with schizophrenia: the paradox of the dually diagnosed

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

7 January 2021

What can we learn about schizophrenia from studying the human model, drug-induced psychosis?

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

7 January 2021

Early adolescent patterns of alcohol, cigarettes, and marijuana polysubstance use and young adult substance use outcomes in a nationally representative sample

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

7 January 2021

Anormalidades cognitivas no uso da cannabis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

7 January 2021

Effects of cannabis use status on cognitive function, in males with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

7 January 2021

Conducting Meta-Analyses in R with the metafor Package

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

7 January 2021

Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

7 January 2021

Neurocognitive functioning of individuals with schizophrenia: using and not using drugs

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

7 January 2021

Cannabis use and cognition in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

7 January 2021

PRISMA for Abstracts: reporting systematic reviews in journal and conference abstracts

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

7 January 2021

Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

7 January 2021

Cannabis: psychological effects of chronic heavy use. A controlled study of intellectual functioning in chronic users of high potency cannabis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

7 January 2021

Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

7 January 2021

The potency of cannabis in New Zealand from 1976 to 1996

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

7 January 2021

Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

7 January 2021

An FMRI study of the influence of a history of substance abuse on working memory-related brain activation in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291715001646

7 January 2021

10.1017/S0033291715001646

Identifiers

DOI

1 reference

15 March 2018

release_hn54dplngnhbxonlgo55h573nu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hn54dplngnhbxonlgo55h573nu

24 November 2022

mapped directly with Wikidata item

PubMed ID

26353818

1 reference

15 March 2018